Series D - Celator Pharmaceuticals
Investment Firm
Overview
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Announced Date
Sep 01, 2010
Closed on Date
Sep 01, 2010
Funding Type
Series D
Highlights
Location
United States, North America
Social
Participant Investors
7
Round Details and Background
Celator Pharmaceuticals raised $20000000 on 2010-09-01 in Series D
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Company Funding History
11
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 10, 2010 |  Venture Round - Celator Pharmaceuticals | - | 2.5M | |
| Dec 28, 2011 | Venture Round - Celator Pharmaceuticals | - | 2.6M | |
| Apr 30, 2013 | Private Equity Round - Celator Pharmaceuticals | 2 | - | 39.3M |
| Sep 01, 2010 | Series D - Celator Pharmaceuticals | 7 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.